ReproCyc ParvoFLEX^® is a new, innovative vaccine that uses an adjuvanted baculovirus vector platform to produce a safe, highly immunogenic and non-virucidal vaccine. This product has been shown to be effective for the vaccination of healthy swine and gilts 6 months of age or older against reproductive failure caused by porcine parvovirus (PPV)

• Protects against new recent strain PPV 27a.
• Produced in a non-pathogenic baculovirus expression system.
• Utilizes DiaTEC technology, a state-of-the-art and novel purification process, which results in a highly immunogenic and safe vaccine.
• Safe in sows in any stage of gestation and lactation.¹
• Aids in the prevention of reproductive disease caused by PPV.²
• Easy to use and ready to be administrated.
• Contains ImpranFLEX^® adjuvant, an effective, aqueous-based (non-oil) polymer adjuvant.
• Proven broad spectrum of protection due to recent strain.³
• Safe vaccine that supports mass vaccination protocols in breeding herds.¹
• Significantly reduces reproductive failure due to PPV.²
• Protects the progeny against transplacental infection caused by PPV.²

Shake well before use. Using aseptic technique, administer a single 2 mL dose by intramuscular injection. Administer a second intramuscular dose 3 weeks later. For more information on revaccination frequency, consult your veterinarian. Safe for use in pregnant animals.

REPROCYC PARVOFLEX Safety Data Sheet (SDS)

Uses

• Mass vaccination or population based PPV control programs.
• Replacement gilt immunization and preparation.
• Reproductive maintenance vaccination program in sows.
• Administration in healthy swine 6 months of age or older to aid in prevention of reproductive disease.

Precautions

• Store out of direct sunlight at 35 – 46°F (2 – 8°C). Do not freeze. Use entire contents when first opened.
• Do not mix with other products.
• Do not vaccinate within 21 days before slaughter.
• In cases of anaphylactoid reaction, administer epinephrine.
• In case of human exposure, contact a physician.